S100 proteins as an important regulator of macrophage inflammation

C Xia, Z Braunstein, AC Toomey, J Zhong… - Frontiers in …, 2018 - frontiersin.org
The S100 proteins, a family of calcium-binding cytosolic proteins, have a broad range of
intracellular and extracellular functions through regulating calcium balance, cell apoptosis …

Unraveling the wide spectrum of melanoma biomarkers

A Revythis, S Shah, M Kutka, M Moschetta, MA Ozturk… - Diagnostics, 2021 - mdpi.com
The use of biomarkers in medicine has become essential in clinical practice in order to help
with diagnosis, prognostication and prediction of treatment response. Since Alexander …

Current concepts of metastasis in melanoma

B Zbytek, JA Carlson, J Granese, J Ross… - Expert review of …, 2008 - Taylor & Francis
The main cause of death in melanoma patients is widespread metastases. Staging of
melanoma is based on the primary tumor thickness, ulceration, lymph node and distant …

[HTML][HTML] S100 protein family and its application in clinical practice

F Sedaghat, A Notopoulos - Hippokratia, 2008 - ncbi.nlm.nih.gov
S100 protein family and its application in clinical practice - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

[HTML][HTML] Biomarkers in melanoma

H Gogas, AMM Eggermont, A Hauschild, P Hersey… - Annals of oncology, 2009 - Elsevier
Biomarkers are tumour-or host-related factors that correlate with tumour biological behaviour
and patient prognosis. High-throughput analytical techniques—DNA and RNA microarrays …

S100 proteins as novel therapeutic targets in psoriasis and other autoimmune diseases

K Kurpet, G Chwatko - Molecules, 2022 - mdpi.com
Psoriasis is one of the most common inflammatory skin diseases affecting about 1–3% of the
population. One of the characteristic abnormalities in psoriasis is the excessive production of …

The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis

S Mocellin, G Zavagno, D Nitti - International journal of cancer, 2008 - Wiley Online Library
S100B protein detected in the serum of patients with cutaneous melanoma has been long
reported as a prognostic biomarker. However, no consensus exists on its implementation in …

[HTML][HTML] Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694

AA Tarhini, J Stuckert, S Lee, C Sander… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma
Patients Participating in Intergroup Trial ECOG 1694 - PMC Back to Top Skip to main content …

Protein and non-protein biomarkers in melanoma: a critical update

N Tandler, B Mosch, J Pietzsch - Amino acids, 2012 - Springer
Melanoma is the most malignant type of all skin neoplasms. Its worldwide incidence has
steadily increased during the past decades, suggesting a probable melanoma 'epidemic' …

Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma

M Neagu, C Constantin, C Tanase - Expert review of molecular …, 2010 - Taylor & Francis
Skin melanoma, a life-threatening disease, has a recently reported worldwide increase in
incidence, despite primary prevention. Skin melanoma statistics emphasize the need for …